{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to msk.org
Memorial Sloan Kettering Cancer Center
  • Sign In
  • Live Courses
  • On Demand eLearning
  • Coming Soon
  • Visiting Us
  • About
  • Resources & Policies
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Select a button below to sign in or create an account. If you have previously registered or attended a MSK CME event, please sign in using the username and password created at course registration. MSK employees must use their SSO credentials to sign in. 

Single Sign On (MSK Employees)
Sign in or Create an Account
Enter your email and password to login:

*
*
Login

New to Memorial Sloan Kettering Cancer Center? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ACHPN
  • ACNP
  • ACNP-BC
  • AGACNP
  • AGACNP-BC
  • AGCNS
  • AGNP
  • AGNP-BC
  • ANP
  • ANP-BC
  • AS
  • AT
  • AuD
  • BA
  • BAO
  • BCC
  • BCh
  • Bchir
  • BM
  • BS
  • BS, MS
  • BSN
  • BSN, MS
  • BSN, MS, DNP
  • CCC-SLP
  • CCLS
  • CCRN
  • CCRP
  • CEN
  • ChB
  • CIPS
  • CNM
  • CNP
  • CPNP
  • CPNP-AC
  • CRNA
  • CRNP
  • CTTS
  • D(ABMM)
  • DAc
  • DACM
  • DAHM
  • DAOM
  • DDS
  • DDS, MPH
  • DMD
  • DMD, PhD
  • DNB
  • DNP
  • DNP, RN
  • DNSc
  • DO
  • DPM
  • DPM
  • DPT
  • DrPH
  • DSc
  • DVM
  • EdD
  • EdS
  • FAAP
  • FACNM
  • FACOG
  • FACS
  • FASCRS
  • FASN
  • FCCM
  • FCCP
  • FIPP
  • FNP
  • FNP-BC
  • GNP
  • GNP-BC
  • HUC
  • JD
  • LAc
  • LCSW
  • LISW
  • LISW-S
  • LMSW
  • LPCC
  • LPN
  • LSW
  • MA
  • MAc
  • MAcOM
  • MB
  • MB, PhD
  • MBA
  • MBBCh
  • MBBCh BAO
  • MBBCh BAO, PhD
  • MBBCh, MPH
  • MBBCh, PhD
  • MBBS
  • MBBS, MPH
  • MBBS, PhD
  • MBChB
  • MD
  • MD, DSc
  • MD, FCCP
  • MD, FCCP, DAABIP
  • MD, JD
  • MD, MA
  • MD, MAS
  • MD, MBA
  • MD, MHA
  • MD, MPH
  • MD, MPH, MHS
  • MD, MS
  • MD, MS, PhD
  • MD, PhD
  • MD, PhD, MA
  • MD, PhD, MPH
  • MD, PhD, MS
  • MDiv
  • MDS
  • MEd
  • MHS
  • MPA
  • MPH
  • MPhil
  • MS
  • MSc
  • MSc, PhD
  • MSN
  • MSPH
  • NCTTP
  • None
  • NP
  • NP, RN
  • OCN
  • OD
  • Other
  • OTR
  • PA
  • PA-C
  • PCA
  • PharmD
  • PharmD, PhD
  • PhD
  • PhD, MBA, MS
  • PhD, MPH
  • PhD, MPhil
  • PhD, MS
  • PhD, MSc
  • PhD, NP, RN
  • PsyD
  • PT
  • RA
  • RCS
  • RD
  • RDCS
  • RDMS
  • RN
  • RN-BC
  • RPh
  • RRT
  • RT
  • ScD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Advances in the Management of Bladder and Kidney Cancer: A Multidisciplinary Approach


Advances in the Management of Bladder and Kidney Cancer: A Multidisciplinary Approach Banner

  • Overview
  • Register
  • Brochure
  • Faculty
  • Schedule
  • Sponsors
Add to Calendar Advances in the Management of Bladder and Kidney Cancer: A Multidisciplinary Approach 10/24/2019 12:00:00 PM 10/26/2019 11:30:00 AM America/New_York For More Details: https://mskcc.cloud-cme.com/Urology2019 Description: The course objective is to advance and disseminate knowledge of new approaches to the multidisciplinary management of bladder and kidney cancer. The program will include comprehensive state-of-the art lectures and discussions encouraging the exchange of ideas between faculty (radiologists, pathologists, surgeons, radiation oncologists, and medical oncologists) and the audience. Discussions will center on the multidiscipli... Zuckerman Research Center, 417 East 68th Street false MM/DD/YYYY


Date & Location
Thursday, October 24, 2019, 12:00 PM - Saturday, October 26, 2019, 11:30 AM, Zuckerman Research Center, 417 East 68th Street

Specialties
Specialties - Diagnostic Radiology, Medical Oncology, Pathology, Radiation Oncology, Urology

Overview

The course objective is to advance and disseminate knowledge of new approaches to the multidisciplinary management of bladder and kidney cancer. The program will include comprehensive state-of-the art lectures and discussions encouraging the exchange of ideas between faculty (radiologists, pathologists, surgeons, radiation oncologists, and medical oncologists) and the audience. Discussions will center on the multidisciplinary management of bladder and kidney cancer.

The intended audience includes urologists, urologic-oncologists, medical oncologists, radiation oncologists, pathologists, radiologists, and allied health professions.

Networking Reception

Course attendees are invited to join the faculty for a networking reception immediately following the conclusion of day one (Thursday, October 24) from 5:00-6:30 pm at Zuckerman Research center. Hors d’oeuvres and refreshments will be served.

Live Simulcast Available*

We are pleased to offer a live simulcast option for the Advances in the Management of Bladder and Kidney Cancer: A Multidisciplinary Approach. CME and ABIM MOC credit is offered for the live simulcast and active participation is required throughout the course. To attend the course via simulcast, please select the "Live Simulcast" option during course registration.

* The Live Simulcast option is not available to MSK Employees. MSK Employees are welcome to attend this course in person. Please register here. 


Objectives
  1. To present a multidisciplinary approach to the management of bladder and kidney cancer including surgery, medical oncology, and radiation therapy.
  2. To advance and disseminate knowledge of new approaches to the multidisciplinary management of bladder and kidney cancer

Registration

 Registration Fees  
 Physicians (MDs, PhDs and DOs)  $600
 Advanced Practice Providers  $450
 Residents, Fellows, Nurses and Other Healthcare Providers     
 $300
 Industry Professionals*  $1,000
 Live Simulcast  $800

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.

Course registration includes continental breakfast, lunch, and refreshment breaks. Please contact [email protected] at least one week prior to the course if you have any special dietary requests or require any specific accommodations.

Registration Discounts/Promotions

  • MSK CME offers a discounted rate for MSK Alumni, MSK Cancer Alliance and Cancer Care Partners. If you are a member of one of these groups, please contact [email protected] for more information.
  • MSK employee registration is complimentary. However, you must complete course registration in order to attend this course. If you are registered for this course and are unable to attend, please email [email protected].

Please note: after your payment has been processed, no further promotional discount adjustments will be made to your registration.

Cancellation Policy

Live Simulcast registrations are non-refundable.

For all other orders, if you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course ([email protected]).

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 16.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 16.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.



*The live broadcast is for streaming use only. By watching this Simulcast you acknowledge that Memorial Sloan Kettering Cancer Center retains all rights, titles and interest in to all copyrights, trademarks, trade secrets, patents and any other proprietary rights to the content of this material. You are not authorized to record this event. You agree to prevent any unauthorized copying, recording, use, distribution and/or re-broadcast of this live simulcast.



Keywords:



 

The aim of this program, presented by faculty from Memorial Sloan Kettering (MSK) and invited speakers, is to highlight new developments in the multidisciplinary management of bladder and kidney cancer.

 

MSK Course Directors

 James A. Eastham, MD, FACS
Chief, Urology Service
Peter T. Scardino Chair in Oncology



Jonathan E. Rosenberg, MD
Chief, Genitourinary Medical Oncology Service

 

MSK Program Planning Committee

Bernard H. Bochner, MD, FACS
Attending Surgeon
Urology Service
Sir Murray Brennan Chair in Surgery



Abraham A. Hakimi, MD
Assistant Attending Surgeon
Urology Service



Gopakumar V. Iyer, MD
Assistant Attending
Bladder Cancer Section Head 
Genitourinary Oncology Service



Martin H. Voss, MD
Assistant Attending
Genitourinary Oncology Service

 

Invited Keynote Speaker  

Brian I. Rini, MD, FACP
Professor of Medicine
Lerner College of Medicine Leader, GU Program
Director, Experimental Therapeutics Fellowship Program
Hematology and Oncology & Glickman Urological and Kidney Institute
Cleveland Clinic Taussig Cancer Institute

 

Invited Course Faculty   

Arjun Balar, MD
Associate Professor of Medicine
Director, Genitourinary Medical Oncology Program
NYU Perlmutter Cancer Center 

James M. McKiernan, MD
Chairman, Urologist-in-Chief
Department of Urology
Columbia University/NewYork-Presbyterian

Brian Shuch, MD
Associate Professor of Urology
Kidney Cancer Program Director
Department of Urology
UCLA School of Medicine

R. Houston Thompson, MD
Professor of Urology
Department of Urology
Mayo Clinic

 

MSK Course Faculty 

Oguz Akin, MD
Attending Radiologist
Director of Body MRI
Department of Radiology

Hikmat Al-Ahmadie, MD
Associate Attending Pathologist
Genitourinary Pathology

Charlotte E. Ariyan, MD, PhD
Associate Attending Surgeon
Gastric and Mixed Tumor Service 

Dean F. Bajorin, MD
Attending Physician
Frederick R. Adler Senior Faculty Chair 
Genitourinary Oncology Service
Professor of Medicine, Weill Cornell Medical College

Bernard H. Bochner, MD, FACS
Attending Surgeon
Urology Service
Sir Murray Brennan Chair in Surgery

Eugene K. Cha, MD
Assistant Attending Surgeon
Urology Service

Timothy A. Chan, MD, PhD
Vice Chair and Attending Physician
Department of Radiation Oncology
Director, Division of Translational Oncology
Directory, Immunogenomics and Precision Oncology Platform
Member, Human Oncology and Pathogeneses Program
 
Yingbei Chen, MD, PhD
Associate Attending Pathologist
Genitourinary Pathology

Marie Carlo, MD
Assistant Attending
Genitourinary Oncology Service

Jonathan A. Coleman, MD
Associate Attending Surgeon
Urology Service

S. Machele Donat, MD, FACS
Attending Surgeon
Urology Service

Jeremy C. Durack, MD, MS
Attending Radiologist
Interventional Radiology Service

James A. Eastham, MD, FACS
Chief, Urology Service 
Peter T. Scardino Chair in Oncology 

Darren R. Feldman, MD
Associate Attending
Genitourinary Oncology Service

Samuel A. Funt, MD
Assistant Attending
Genitourinary Oncology Service

Alvin C. Goh, MD
Associate Attending Surgeon
Urology Service

Abraham A. Hakimi, MD
Assistant Attending Surgeon
Urology Service

Harry W. Herr, MD
Attending Surgeon
Urology Service

Gopakumar V. Iyer, MD
Assistant Attending
Bladder Cancer Section Head 
Genitourinary Oncology Service

Marisa A. Kollmeier, MD
Associate Attending Physician
Chair, Radiation Oncology Quality Assurance
Brachytherapy Service

Chung-Han Lee, MD, PhD
Assistant Attending
Genitourinary Oncology Service

Robert J. Motzer, MD
Attending
Genitourinary Oncology Service

Eugene Pietzak, MD
Assistant Attending Surgeon
Urology Service
Brachytherapy Service

Paul Russo, MD
Attending Surgeon
Urology Service
Professor of Urology, Weill Cornell College of Medicine

Jonathan E. Rosenberg, MD
Chief, Genitourinary Medical Oncology Service
Division of Solid Tumor Oncology
Enno W. Ercklentz Chair

Min Yuen Teo, MD
Assistant Attending
Genitourinary Oncology Service

Martin H. Voss, MD
Assistant Attending
Genitourinary Oncology Service

 

Faculty Disclosures (All Faculty)



Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Jonathan E Rosenberg, MD
MSK
Activity Co-Director, Faculty
In kind services-Roche|Consulting Fee-GlaxoSmithKline|Consulting Fee-Astellas|Contracted Research-AstraZeneca|Consulting Fee-AstraZeneca|Consulting Fee-Sensei Biotherapeutics|Consulting Fee-Bristol-Myers Squibb|Consulting Fee-Seattle Genetics|Consulting Fee-Pharmacyclics, Inc.|Consulting Fee-western oncolytics|Consulting Fee-Mirati Therapeutics|Consulting Fee-Merck and Company, Inc.|Consulting Fee-QED Therapeutics|Consulting Fee-BioClin Therapeutics|Consulting Fee-Adicet Bio|Consulting Fee-Fortress Biotech|Honoraria-Chugai|Consulting Fee-Bayer Corporation|Contracted Research-Genentech, Inc.|Contracted Research-Astellas|Contracted Research-Novartis AG|Contracted Research-Seattle Genetics|Contracted Research-Bayer Corporation
Oguz Akin, MD
MSK
Faculty
Nothing to disclose
Hikmat Al-Ahmadie, MD
MSK
Usa
Faculty
Consulting Fee-Bristol-Myers Squib Aventis|Consulting Fee-AstraZeneca
Arlyn J. Apollo, MD, MPH
MSK
Faculty
Nothing to disclose
Charlotte E Ariyan, MD, PhD
MSK
Usa
Faculty
Ownership Interest-Pfizer, Inc.
Dean Bajorin, MD
MSK
Faculty
Consultancy, Honoraria and Research Funding-Novartis, Merck, Merck Sharpe and Dome, Fidia Farmaceutici, Bristol-Myers Squibb, Astra Zeneca, Eli- Lilly, Genentech, Roche, and Pfizer.
Arjun Balar, MD
NYU Perlmutter Cancer Center
Faculty
Consulting Fee-Merck and Company, Inc.|Contracted Research-Merck and Company, Inc.|Consulting Fee-AstraZeneca|Contracted Research-AstraZeneca|Consulting Fee-EMD Serono|Consulting Fee-Genentech, Inc.|Contracted Research-Genentech, Inc.
Maria Carlo, MD
MSK
Faculty
Nothing to disclose
Eugene K Cha, MD
MSK
Faculty
Nothing to disclose
Timothy A Chan, MD, PhD
MSK
Faculty
Yingbei Chen, MD, PhD
MSK
Faculty
Nothing to disclose
Jonathan Coleman, MD
MSK
Faculty
Nothing to disclose
Timothy Donahue, MD
MSK
Faculty
Nothing to disclose
Sherri Donat, MD
MSK
Faculty
Nothing to disclose
Jeremy Durack, MD, MS
MSK
Faculty
Scientific Advisory Board, Investor-Adient Medical
James A Eastham, MD,FACS
MSK
Faculty
Consulting Fee-3D Biopsy
Darren Feldman, MD
MSK
Faculty
Contracted Research-Research funding-Seattle Genetics|Contracted Research-Novartis AG|Royalty-UpToDate (not a manufacturer but rather a content publisher)
Samuel A. Funt, MD
MSK
Faculty
Ownership Interest-Kite Pharma|Ownership Interest-Kronos Bio|Ownership Interest-Urogen Pharma|Contracted Research-Genentech, Inc.|Contracted Research-AstraZeneca|Ownership Interest-Allogene Therapeutics |Ownership Interest-Neogene Therapeutics|Ownership Interest-Vida Ventures
Alvin Goh, MD
MSK
Faculty
Nothing to disclose
Harry Herr, MD
MSK
Faculty
Nothing to disclose
Marisa Kollmeier, MD
MSK
Faculty
Nothing to disclose
Chung-Han Lee, MD
MSK
Faculty
Consulting Fee-Exelexis|Consulting Fee-Bristol-Myers Squibb|Consulting Fee-Amgen|Consulting Fee-Eisai, Inc.|Contracted Research-Bristol-Myers Squibb|Contracted Research-Calithera|Contracted Research-Eisai, Inc.|Contracted Research-Eli Lilly and Company|Contracted Research-Exelixis|Contracted Research-Pfizer, Inc.
James McKiernan, MD
Columbia University/NYPH
Faculty
Nothing to disclose
Robert Motzer, MD
MSK
Faculty
Consulting Fee-Pfizer, Exelixis, Genentech Roche, Merck, Eli Lilly|Contracted Research-Pfizer, Exelixis, Eisai, Genentech Roche, Bristol Myers Squibb
Eugene Pietzak, MD
MSK
Faculty
Consulting Fee-Merck and Company, Inc.|Consulting Fee-Chugai Pharmaceutical
Brian Rini, MD
Cleveland Clinic Taussig Cancer Institute
Faculty
Consulting Fee-Pfizer, Inc.|Consulting Fee-Bristol-Myers Squibb|Consulting Fee-Merck and Company, Inc.|Consulting Fee-Roche|Consulting Fee-Arrowhead|Contracted Research-Pfizer, Inc.|Contracted Research-Merck and Company, Inc.|Contracted Research-Bristol-Myers Squibb|Contracted Research-AstraZeneca|Contracted Research-Roche
Paul Russo, MD
MSK
Faculty
Nothing to disclose
Brian Shuch, MD
UCLA School of Medicine
Faculty
Nothing to disclose
Min Yuen Teo, MB BCh, BAO
MSK
Faculty
Nothing to disclose
R. Houston Thompson, MD
Mayo Clinic
Faculty
Nothing to disclose
Han Xiao, MD
MSK
Faculty
Nothing to disclose
Bernard Bochner, MD
MSK
Faculty, Planner
Consulting Fee-Olympus|Consulting Fee-Genentech, Inc.
Abraham A Hakimi, MD
MSK
Faculty, Planner
Nothing to disclose
Gopakumar Iyer, MD
MSK
Faculty, Planner
Consulting Fee-Johnson and Johnson|Consulting Fee-Mirati Therapeutics|Speakers Bureau-DAVA Oncology
Martin H Voss, MD
MSK
Faculty, Planner
Consulting Fee-Exelixis|Consulting Fee-Eisai, Inc.|Consulting Fee-Pfizer, Inc.|Consulting Fee-Corvus|Contracted Research-Bristol-Myers Squibb|Contracted Research-Genentech, Inc.

Thursday, October 24, 2019
 
Thursday, Oct 24

SYLLABUS DISCLAIMER
8:00AM - 8:10AM

Please be aware only the presentations from faculty that

have given their consent will be available below


Disclosure
8:10AM - 8:20AM
Welcome and Opening Remarks
12:50PM - 1:00PM
Jonathan E Rosenberg, MD
VIDEO: Updates on Natural History of High Risk NIMBC
1:00PM - 1:15PM
Bernard Bochner, MD
NMIBC Molecular Biology
1:15PM - 1:40PM
Eugene Pietzak, MD
New Detection Technologies: Blue Light and NBI
1:40PM - 2:00PM
James McKiernan, MD
VIDEO: New Detection Technologies: Blue Light and NBI
1:40PM - 2:00PM
James McKiernan, MD
Management of BCG - Unresponsive NMIBC
2:00PM - 2:15PM
Eugene K Cha, MD
VIDEO: Management of BCG - Unresponsive NMIBC
2:00PM - 2:15PM
Eugene K Cha, MD
Role of Checkpoint Inhibitors for NMIBC
2:15PM - 2:30PM
Dean Bajorin, MD
VIDEO: Role of Checkpoint Inhibitors for NMIBC
2:15PM - 2:30PM
Dean Bajorin, MD
VIDEO: Case Discussion I: BCG Shortage; Optimal BCG, Selection for Early Cystectomy; Persistent Positive Cytology (Natural History, Surveillance vs. Therapy)
2:30PM - 3:00PM
James McKiernan, MD
Dean Bajorin, MD
Eugene K Cha, MD
Harry Herr, MD
SRM – Epidemiology and Treatment Molecular (Overtreatment)
3:10PM - 3:25PM
Abraham A Hakimi, MD
VIDEO: SRM – Epidemiology and Treatment Molecular (Overtreatment)
3:10PM - 3:25PM
Abraham A Hakimi, MD
Biopsy
3:25PM - 3:40PM
Yingbei Chen, MD, PhD
VIDEO: Biopsy
3:25PM - 3:40PM
Yingbei Chen, MD, PhD
Surveillance and Genomics
3:55PM - 4:10PM
Brian Shuch, MD
VIDEO: Surveillance and Genomics
3:55PM - 4:10PM
Brian Shuch, MD
Novel Imaging in RCC
4:10PM - 4:30PM
Oguz Akin, MD
VIDEO: Novel Imaging in RCC
4:10PM - 4:30PM
Oguz Akin, MD
Case Discussion II: Multifocal Renal Masses, SRM in Elderly
4:30PM - 5:00PM
Brian Shuch, MD
Jonathan Coleman, MD
Jeremy Durack, MD, MS
Abraham A Hakimi, MD
Paul Russo, MD
VIDEO: Case Discussion II: Multifocal Renal Masses, SRM in Elderly
4:30PM - 5:00PM
Brian Shuch, MD
Jonathan Coleman, MD
Jeremy Durack, MD, MS
Abraham A Hakimi, MD
Paul Russo, MD
Friday, October 25, 2019
 
Friday, Oct 25

SYLLABUS DISCLAIMER
7:30AM - 7:40AM

Please be aware only the presentations from faculty that

have given their consent will be available below


Disclosure
7:40AM - 7:50AM
Emerging Paradigms in the Upfront Management of Metastatic Kidney Cancer
8:00AM - 8:45AM
Brian Rini, MD
VIDEO: Emerging Paradigms in the Upfront Management of Metastatic Kidney Cancer
8:00AM - 8:45AM
Brian Rini, MD
Partial vs Radical for >= pT1b
9:15AM - 9:30AM
Paul Russo, MD
VIDEO: Partial vs Radical for >= pT1b
9:15AM - 9:30AM
Paul Russo, MD
LN Dissection
9:30AM - 9:45AM
R. Houston Thompson, MD
VIDEO: LN Dissection
9:30AM - 9:45AM
R. Houston Thompson, MD
Perioperative Therapy in the Non-metastatic Setting
9:45AM - 10:00AM
Martin H Voss, MD
VIDEO: Perioperative Therapy in the Non-metastatic Setting
9:45AM - 10:00AM
Martin H Voss, MD
Case Discussion III: Large Renal Masses, Node Positive, Solitary Kidney
10:15AM - 11:00AM
VIDEO: Case Discussion III: Large Renal Masses, Node Positive, Solitary Kidney
10:15AM - 11:00AM
Neoadjuvant Therapy for Cis-eligible Patients (Cisplatin-based Chemotherapy, IO+Chemotherapy Trials)
11:10AM - 11:25AM
Gopakumar Iyer, MD
VIDEO: Neoadjuvant Therapy for Cis-eligible Patients (Cisplatin-based Chemotherapy, IO+Chemotherapy Trials)
11:10AM - 11:25AM
Gopakumar Iyer, MD
Adjuvant Therapy for MIBC (Including Data on Standard and Novel Therapies)
11:25AM - 11:35AM
Min Yuen Teo, MB BCh, BAO
VIDEO: Adjuvant Therapy for MIBC (Including Data on Standard and Novel Therapies)
11:25AM - 11:35AM
Min Yuen Teo, MB BCh, BAO
Importance of Germline Mutations in Urothelial Cancer
11:35AM - 11:45AM
Maria Carlo, MD
VIDEO: Importance of Germline Mutations in Urothelial Cancer
11:35AM - 11:45AM
Maria Carlo, MD
VIDEO: Open vs Robotic Surgery for MIBC: Update of Current Data
11:45AM - 12:00PM
Bernard Bochner, MD
RARC: How to. Tips and Tricks
12:00PM - 12:20PM
Alvin Goh, MD
VIDEO: RARC: How to. Tips and Tricks
12:00PM - 12:20PM
Alvin Goh, MD
2nd Line Therapy and Beyond: Approved Agents and Their Application in the Post-IO Space
1:30PM - 1:50PM
Chung-Han Lee, MD
VIDEO: 2nd Line Therapy and Beyond: Approved Agents and Their Application in the Post-IO Space
1:30PM - 1:50PM
Chung-Han Lee, MD
Risk Stratification and Molecular Classifiers in the Metastatic Setting
1:50PM - 2:20PM
Martin H Voss, MD
VIDEO: Risk Stratification and Molecular Classifiers in the Metastatic Setting
1:50PM - 2:20PM
Martin H Voss, MD
Case Discussions:RCC Management in the Metastatic Setting
2:20PM - 2:40PM
Maria Carlo, MD
Chung-Han Lee, MD
Robert Motzer, MD
VIDEO: Case Discussions:RCC Management in the Metastatic Setting
2:20PM - 2:40PM
Maria Carlo, MD
Chung-Han Lee, MD
Robert Motzer, MD
Molecular Biology of MIBC - Role in Bladder Preservation
3:00PM - 3:20PM
Gopakumar Iyer, MD
VIDEO:Molecular Biology of MIBC - Role in Bladder Preservation
3:00PM - 3:20PM
Gopakumar Iyer, MD
Trimodal Therapy for MIBC
3:20PM - 3:35PM
Marisa Kollmeier, MD
VIDEO: Trimodal Therapy for MIBC
3:20PM - 3:35PM
Marisa Kollmeier, MD
Case Discussions: The Role of Bladder Preservation in MIBC
3:35PM - 4:00PM
Harry Herr, MD
Gopakumar Iyer, MD
Marisa Kollmeier, MD
VIDEO:Case Discussions: The Role of Bladder Preservation in MIBC
3:35PM - 4:00PM
Harry Herr, MD
Gopakumar Iyer, MD
Marisa Kollmeier, MD
Upper Tract TCC Molecular Differences and Clinical Management of UTUC
4:00PM - 4:15PM
Jonathan Coleman, MD
VIDEO: Upper Tract TCC Molecular Differences and Clinical Management of UTUC
4:00PM - 4:15PM
Jonathan Coleman, MD
Histologic Variants of Bladder Cancer
4:15PM - 4:30PM
Hikmat Al-Ahmadie, MD
VIDEO: Histologic Variants of Bladder Cancer
4:15PM - 4:30PM
Hikmat Al-Ahmadie, MD
Case Discussions: Clinical Management of Histologic Variants
4:30PM - 5:00PM
Hikmat Al-Ahmadie, MD
Bernard Bochner, MD
Sherri Donat, MD
Marisa Kollmeier, MD
Jonathan E Rosenberg, MD
VIDEO: Case Discussions: Clinical Management of Histologic Variants
4:30PM - 5:00PM
Hikmat Al-Ahmadie, MD
Bernard Bochner, MD
Sherri Donat, MD
Marisa Kollmeier, MD
Jonathan E Rosenberg, MD
Saturday, October 26, 2019
 
Saturday, Oct 26

SYLLABUS DISCLAIMER
7:30AM - 7:40AM

Objectives:

Please be aware only the presentations from faculty that

have given their consent will be available below

Disclosure
7:40AM - 7:50AM
Surgical Safety in IO Treated Patients
8:20AM - 8:40AM
Charlotte E Ariyan, MD, PhD
VIDEO: Surgical Safety in IO Treated Patients
8:20AM - 8:40AM
Charlotte E Ariyan, MD, PhD
IO Tox Management
8:40AM - 9:00AM
Samuel A. Funt, MD
VIDEO: IO Tox Management
8:40AM - 9:00AM
Samuel A. Funt, MD
Cytoreduction + Metastasectomy
9:00AM - 9:30AM
Paul Russo, MD
VIDEO:Cytoreduction + Metastasectomy
9:00AM - 9:30AM
Paul Russo, MD
VIDEO: Case Discussions: Multidisciplinary Approaches to Metastatic Kidney Cancers
9:30AM - 9:40AM
Maria Carlo, MD
Darren Feldman, MD
Paul Russo, MD
Familial Predisposition Syndromes and Germline Testing in RCC
9:40AM - 10:00AM
Maria Carlo, MD
VIDEO: Familial Predisposition Syndromes and Germline Testing in RCC
9:40AM - 10:00AM
Maria Carlo, MD
Systemic Therapy for Metastatic Non-clear Cell RCC
10:00AM - 10:20AM
Darren Feldman, MD
VIDEO: Systemic Therapy for Metastatic Non-clear Cell RCC
10:00AM - 10:20AM
Darren Feldman, MD
Emerging Regimens for Metastatic RCC
10:20AM - 10:30AM
Chung-Han Lee, MD
VIDEO: Emerging Regimens for Metastatic RCC
10:20AM - 10:30AM
Chung-Han Lee, MD
IO Therapy for Advanced Bladder Cancer: Data for IO in the 1st Line Metastatic Setting
10:30AM - 10:50AM
Jonathan E Rosenberg, MD
VIDEO: IO Therapy for Advanced Bladder Cancer: Data for IO in the 1st Line Metastatic Setting
10:30AM - 10:50AM
Jonathan E Rosenberg, MD
Predictive Biomarkers and Novel Metastatic Options (ADC, FGFR3 Inhibition)
10:50AM - 11:10AM
Arjun Balar, MD
VIDEO: Predictive Biomarkers and Novel Metastatic Options (ADC, FGFR3 Inhibition)
10:50AM - 11:10AM
Arjun Balar, MD
Case Discussions: Management of Metastatic Bladder Cancer in the Immunotherapy Era
11:10AM - 11:30AM
Arjun Balar, MD
Samuel A. Funt, MD
Jonathan E Rosenberg, MD
VIDEO: Case Discussions: Management of Metastatic Bladder Cancer in the Immunotherapy Era
11:10AM - 11:30AM
Arjun Balar, MD
Samuel A. Funt, MD
Jonathan E Rosenberg, MD

Memorial Sloan Kettering gratefully acknowledges the following organizations for providing educational grants for this live activity:

Astellas and Seattle Genetics
AstraZeneca
Bristol-Myers Squibb
Ethicon
Merck


CME Courses

Live Courses
On Demand eLearning
Coming Soon

Resources & Policies

CME Program Terms of Use
Registration Discounts
Cancellation Policy
Industry Professionals

Attendee & Faculty Information

My CME / Attendee Resources
Claim RSS Credit (MSK Staff)
Faculty Disclosure Form
Faculty Tasks Page

Connect

Locations & Visitor Info
Help / Contact Us
Subscribe to CME Announcements




MSK CME

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

©2025 Memorial Sloan Kettering Cancer Center